QHSLab, Inc. (USAQ): R&D Expense
$484.9K
Year ended 2025-12-31
$484.0K
Trailing 12 months to 2026-06-30
+36.6%
3-year compound annual growth
+37.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $484.9K | +64.7% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $294.5K | +37.6% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $214.0K | +12.6% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $190.1K | +109.2% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $90.9K | -7.5% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $98.3K | -1.9% | 2022-04-01, From 2020-01-01 |
| 2019-12-31 | $100.2K | n/a | 2021-03-11, From 2019-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| QHSLab, Inc. (USAQ) | 2025-12-31 | $484.9K | +64.7% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $318.4K | +97.6% |
| Femasys Inc (FEMY) | 2025-12-31 | $7.58M | -7.8% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $7.43M | +4.7% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $2.15M | -17.4% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $5.68M | -5.2% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $3.05M | -9.8% |
Compare USAQ, OSRH, FEMY, ICCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗